Autoantibody Diagnostics in Autoimmune Liver Diseases
The new tests systems, called Anti-Sp100, Anti-gp210, Anti-LKM-1, and Anti-SLA, reliably detect specific autoantibodies that are characteristic of various autoimmune liver diseases. The tests thus also allow for reliable differentiation between these autoimmune diseases and other diseases of the liver, such as viral infections, based on blood samples.
Autoimmune liver diseases are caused by a malfunctioning immune system. This category of diseases includes autoimmune hepatitis (AIH), primary biliary cirrhosis (PBC), and primary sclerosing cholangitis (PSC). As it is mostly the case, these diseases are treatable if they are detected early; if left untreated, they can lead to severe symptoms and considerable damage to the liver.
If a physician is dealing with ambiguous symptoms or needs to clarify unusual blood values, the detection of characteristic autoantibodies provides a clear indicator of autoimmune liver diseases. For instance, if Sp100 or gp210 antibodies are detected, it is most likely a case of primary biliary cirrhosis. Antibodies against LKM-1 or SLA are indicative of autoimmune hepatitis.
The triggers of autoimmune liver disease are largely unknown. They may be caused by previous or on-going infections. It is also possible that genetic predisposition may favour the development of these disorders.
For the first time, these newly introduced laboratory tests, Anti-SP100, Anti-gp210, Anti-LKM-1, and Anti-SLA, allow for the individualised, rapid, and fully automated detection of the corresponding autoantibodies. They are suitable for cost-efficient differential diagnostics or for the differentiation of positive screening results from other ELISA, immunoblot tests or immunofluorescence assays. – www.orgentec.com
Based in Mainz, ORGENTEC Diagnostika is a global leader in the development and marketing of test systems for autoimmune diagnostics and serological tests for infectious disease. ORGENTEC has developed numerous highly specific ELISA test systems, immunoblot and immunofluorescence tests, the Alegria® random access analyser, and the rheumachec® rapid test. – www.orgentec.com
ORGENTEC Diagnostika GmbH
Dr. Friederike Hammar
55129 Mainz, Germany
Tel. +49 (0) 6131 9258-677, -674
Fax +49 (0) 6131 9258-58
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Autoantibody Diagnostics in Autoimmune Liver Diseases here
News-ID: 212654 • Views: 1364
More Releases from ORGENTEC Diagnostika
Fully Automated Chlamydia Diagnostics from ORGENTEC
Mainz, June 19, 2012 – ORGENTEC Diagnostika (www.orgentec.com) has introduced six new tests for the diagnosis of infectious diseases. The new ELISA tests detect antibodies against Chlamydia trachomatis and Chlamydia pneumoniae. In addition, these test systems make it possible to differentiate between acute, latent, and chronic infection with these widespread bacterial pathogens. The new tests for the serological diagnosis of Chlamydia were developed specifically for Alegria®, ORGENTEC Diagnostika’s random access analyser.
Online Immunofluorescence Guide for Diagnosis of Autoimmune Diseases
Mainz, May 09 2012 – From now on the Immunofluorescence Guide for the Modern Autoimmunity Laboratory is available as a free ebook. The online reference work with numerous pictures of immunofluorescence patterns is accessible from the ORGENTEC Diagnostika website (www.orgentec.com) and from the website of the GRÜNE CLUB AUTOIMMUN (www.der-gruene-club.at). The online guide is public domain without login or registration. Whether it is the immunofluorescence pattern of antinuclear antibodies (ANA) on
A New Healthcare App: ORGENTEC Autoimmunity Guide
The ORGENTEC Autoimmunity Guide is now available for download from the Apple iTunes App Store and the Android Market. This app from Mainz-based ORGENTEC Diagnostika GmbH (www.orgentec.com) makes it possible to call up information about autoimmune diseases easily and comfortably from a smartphone or tablet – precisely, compactly, and without extensive searching. The ORGENTEC app offers comprehensive information about the diagnosis and monitoring of autoimmune diseases by means of antibody detection.
Autoimmune Disease Diagnostics: High Sensitivity ACPA Test for Rheumatoid Arthri …
Mainz, November 16, 2011 – For Medica 2011, ORGENTEC Diagnostika presents a new laboratory test for the diagnosis of rheumatism. The highly sensitive Anti-CCP hs (high sensitive)® test makes possible the early diagnosis of rheumatoid arthritis (RA), which in turn allows for successful treatment of this autoimmune disease. The new Anti-CCP hs (high sensitive)® test is the most recent development in the area of ACPA testing. This innovate enzyme immunoassay combines
More Releases for ELISA
Global Enzyme-linked Immunosorbent Assay (ELISA）Analyzers Market Research Repo …
This report studies the global Enzyme-linked Immunosorbent Assay (ELISA）Analyzers market status and forecast, categorizes the global Enzyme-linked Immunosorbent Assay (ELISA）Analyzers market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report Thermo Fisher PerkinElmer Tecan BioTek EUROIMMUN DiaSorin BIO-RAD Molecular Devices Dynex Technologies BMG
Global ELISA Analyzers Market Research Report
This report studies the global ELISA Analyzers market status and forecast, categorizes the global ELISA Analyzers market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report Thermo Fisher PerkinElmer Tecan BioTek EUROIMMUN DiaSorin BIO-RAD Molecular Devices Dynex Technologies BMG Labtech KHB Promega Trinity
Global ELISA Processors Market Research Report 2018
In this report, the global ELISA Processors market is valued at USD million in 2017 and is expected to reach USD million by the end of 2025, growing at a CAGR between 2017 and 2025. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of ELISA Processors in these regions, from 2013 to 2025 (forecast), covering
ELISA Analyzer Market trend, outlook 2025
Enzyme Linked Immunosorbent Assay (ELISA) is a biochemical assay, which use antibodies and an enzyme-mediated color change to detect the presence of either antigen (proteins, peptides, and hormones) or antibody in sample. Enzyme-linked immunosorbent assay is used as diagnostic tool in medicine and analytical tool in biomedical research. ELISA analyzer is an instrument used for detecting the concentration and presence of analyte in the test sample. ELISA analyzer can be
ELISA Reagents Market Research Report : 2017
Reports And Markets Publish a New Market Research Report On –" ELISA Reagents Market Research Report 2017" Access Full Report With Table Of Contents @ https://www.reportsandmarkets.com/reports/global-elisa-reagents-market-research-report-2017-1541198 In this report, the global ELISA Reagents market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key
Global ELISA Reagents Sales Market Report 2017
The Global ELISA Reagents Sales Market Report 2017 is a professional and in-depth study on the current state of the ELISA Reagents industry. Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The ELISA Reagents market analysis is provided for the international market including development history, competitive landscape analysis, and major regions’ development status. Secondly, development policies and plans are discussed as well as manufacturing processes and cost